<DOC>
	<DOCNO>NCT00293709</DOCNO>
	<brief_summary>The purpose study evaluate safety profile effectiveness etanercept usual care setting patient PsA treat dermatologist .</brief_summary>
	<brief_title>Study Evaluating Safety Efficacy Etanercept Patients With Psoriatic Arthritis Treated Dermatologists</brief_title>
	<detailed_description>Non-interventional study : subject select accord usual clinical practice physician</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Skin Diseases , Papulosquamous</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Clinical diagnosis Psoriatic Arthritis Sepsis risk sepsis , Acute infection , Hypersensitive Etanercept</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Arthritis</keyword>
</DOC>